Summary of Purpose
The objective of this study is to determine if the action of the drug called clopidogrel, that you will start taking, will be decreased by another drug called atorvastatin, that you will also start taking. Clopidogrel is an oral antiplatelet agent that has been shown to prevent strokes and heart attacks. Atorvastatin is a cholesterol lowering agent. Twenty adults 18-75 years of age requiring...Read More →
The following dates are available for this trial. Trial information last updated on 23 June 2005.
|Unavailable||11 Feb 2000||Unavailable||Unavailable||1 Dec 2003||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Allocation: Randomized
- Masking: Open Label
- Purpose: Treatment
- Intervention: Parallel Assignment
- Wei C. Lau, M.D.